Last Updated:

Invent Bio-Med Private Limited loan details

Charges taken from banks & financial institutes

Data last updated:

Amount in (₹)

Invent Bio-Med Private Limited has 7 charges registered with the Registrar of Companies: 1 open charge worth Rs 8.50 Cr and 6 satisfied charges worth Rs 25.08 Cr. The most recent charge was created on 05 Sep 2025 for Rs 8.50 Cr and is open.

Charges Breakdown by Lending Institutions

  • Others : 8.50 Cr

₹8.50 crore

₹25.08 crore

4

Punjab National Bank

Creation

05 Sep 2025

₹8.50 cr

Charge IdLenderAmountCreation DateLast Modification DateSatisfaction DateStatus
10363011 View DetailsPunjab National Bank₹ 9.10 12 Jun 201212 Dec 201311 Oct 2019 Satisfied 90992000.0
10295453 View DetailsPunjab National Bank₹ 7.23 07 Jul 201128 Nov 201111 Oct 2019 Satisfied 72300000.0
10110653 View DetailsPunjab National Bank₹ 6.30 26 Mar 200814 Oct 200911 Oct 2019 Satisfied 63000000.0
10340899 View DetailsSmall Industries Development Bank Of India₹ 0.35 27 Jan 201201 Feb 201205 Sep 2019 Satisfied 3500000.0
10059406 View DetailsBank Of Baroda₹ 1.05 15 Jun 2007-24 Dec 2009 Satisfied 10500000.0
10059407 View DetailsBank Of Baroda₹ 1.05 15 Jun 2007-24 Dec 2009 Satisfied 10500000.0
101176822 View DetailsOthers₹ 8.50 05 Sep 2025-- Open 85000000.0
Premium access

Charge documents and asset details

The filed charge documents and the assets pledged under each charge are in the company report.

  • Assets and property pledged under each charge
  • Terms and conditions as filed
  • Filed charge documents where available

Verified entity values are shown only after access is granted.

A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.